Compass Therapeutics, Inc. Stock OTC Markets
Stocks
CMPX
US20454B1044
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.550 USD | -10.80% |
|
+32.67% | - |
| Market Cap | 375M 328M 303M 283M 531M 35.34B 543M 3.64B 1.41B 17.46B 1.41B 1.38B 60.56B | P/E 2026 * |
-4.75x | P/E 2027 * | -4.47x |
|---|---|---|---|---|---|
| Enterprise Value | 225M 197M 182M 170M 319M 21.19B 325M 2.18B 844M 10.47B 843M 825M 36.31B | EV / Sales 2026 * |
-101x | EV / Sales 2027 * | 9.45x |
| Free-Float |
87.55% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Compass Therapeutics, Inc.
| 1 day | -10.80% |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Schuetz
CEO | Chief Executive Officer | 65 | 2024-05-27 |
Barry Shin
DFI | Director of Finance/CFO | 54 | 2024-12-08 |
Cynthia Sirard
CTO | Chief Tech/Sci/R&D Officer | 56 | 2025-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Richard Lindahl
BRD | Director/Board Member | 62 | 2023-04-20 |
Mary Gray
BRD | Director/Board Member | 73 | 2022-04-24 |
Ellen Chiniara
BRD | Director/Board Member | 67 | 2022-04-24 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -10.80% | +32.67% | - | - | 375M | |
| +0.33% | +1.37% | +64.03% | +119.11% | 55.63B | |
| +0.82% | +15.05% | +79.93% | +84.34% | 52.25B | |
| +1.36% | +0.36% | -14.06% | -14.69% | 23.07B | |
| -1.04% | +7.91% | +1.61% | +419.24% | 22.41B | |
| -0.18% | +7.20% | +32.16% | -14.07% | 17.32B | |
| -1.10% | +4.00% | +28.70% | -34.51% | 15.94B | |
| -3.35% | +8.96% | +132.20% | +290.18% | 13.47B | |
| +2.89% | +5.51% | +27.11% | +181.45% | 13.77B | |
| +1.31% | +0.53% | +28.62% | - | 12.43B | |
| Average | -0.98% | +4.78% | +42.26% | +128.88% | 25.14B | |
| Weighted average by Cap. | +0.24% | +5.13% | +48.50% | +120.17% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | -2.22M -1.94M -1.79M -1.68M -3.14M -209M -3.21M -21.52M -8.33M -103M -8.32M -8.14M -358M | 25.67M 22.51M 20.75M 19.43M 36.43M 2.42B 37.18M 249M 96.5M 1.2B 96.41M 94.3M 4.15B |
| Net income | -82.94M -72.72M -67.03M -62.76M -118M -7.82B -120M -806M -312M -3.87B -311M -305M -13.41B | -89.85M -78.78M -72.62M -67.98M -127M -8.48B -130M -873M -338M -4.19B -337M -330M -14.53B |
| Net Debt | -150M -132M -121M -113M -213M -14.15B -217M -1.46B -564M -6.99B -563M -551M -24.25B | -132M -116M -107M -99.88M -187M -12.45B -191M -1.28B -496M -6.15B -496M -485M -21.34B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CMPX Stock
- CMPX Stock
Select your edition
All financial news and data tailored to specific country editions
